464 results found

In Fernandes v. Araujo the Ontario Court of Appeal overturned one of its own previous decisions, clarifying a half-century old area of confusion in the law on vicarious liability for vehicle owners.

Latest developments in the Life Sciences industries.

The arrival of connected and autonomous vehicles (CAVs) feels both imminent and far away. Even as we increasingly rely on automation in our daily lives, the idea of self-driving cars...

The Government of Canada is moving apace to implement its zero plastic waste agenda, which includes developing and implementing new regulations for plastic manufactured items under...

The Alberta Court of Appeal recently overturned a class certification order and made important comments on a representative plaintiff's evidentiary burden at the certification stage, as well as on...

A Significant Win for a Pharmaceutical Company in a Product Liability Class Action

A new study says that while autonomous vehicle technology has great promise to reduce crashes, it may not be able to prevent all mishaps caused by human error.

Product liability law is the name placed on a combination of several branches of the law, including contract, tort, government regulation, damages, and insurance.

On April 30, 2018, the Ontario Court of Appeal released its decision in 1688782 Ontario Inc. v. Maple Leaf Foods Inc. and Maple Leaf Consumer Foods Inc., 2018 ONCA 407 ("Maple Leaf Foods Inc.").

The Canada Consumer Product Safety Act (CCPSA), which came into force on June 20, 2011, significantly changes Canada’s approach to consumer product regulation and recalls.

The latest report from Gowlings relating to developments in the Life Sciences Industry.

On March 27, 2024, the Court of Appeal for Ontario released its much awaited decision in Palmer v. Teva. The decision sends a clear signal that claims based on weak science...

Used car prices, one of the biggest drivers of U.S. inflation this year, rose again in early September on a monthly basis after idling over the summer.

The Product Liability and Mass Torts Group at McCarthy Tétrault LLP is pleased to bring you our analysis of recent decisions for businesses manufacturing or selling products in Canada.

Deciding whether or not to launch a food, drug, medical device, dietary supplement or cosmetic product in Canada involves a number of considerations.

Bill C-36, the "Canada Consumer Product Safety Act" (the Act), has passed through the House of Commons and the Senate and received Royal Assent on December 15th. It is due to be proclaimed in force by the Governor in Council shortly.

Comme les années précédentes, les actions collectives devraient demeurer un sujet de préoccupation pour le secteur automobile en 2021, compte tenu des efforts grandissants pour faire autoriser des...